Effects of Calamansi on Blood Glucose

Blood Glucose Response Clinical Trial

Official title:

Blood Glucose Response to a Calamansi Drink in Healthy Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04462016
• Other study ID #: MDP20505_2017/2018_MS0001
• Status: Completed
• Phase: N/A
• Start date: February 2, 2018
• Est. completion date: August 8, 2018

Study information

• Verified date: July 2020
• Source: University Malaysia Sarawak
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is important to bring the blood glucose levels of those with type 2 diabetes mellitus (T2DM) back to normal levels as this can stop the condition from worsening and prevent other conditions that are related to T2DM from developing. One way to maintain healthy blood glucose level is the use of the glycaemic index (GI), which ranks food according to how the body responds to its carbohydrate content. Low GI foods corresponds to low increase in blood glucose levels. Calamansi is a citrus that is believed not to induce an increase in blood glucose levels. Since beverages from calamansi are available and diabetes is a health concern in the community, it is important to investigate the effect of consuming this drink. Finger prick blood were tested in order to obtain the blood glucose levels for calculating the GI for the calamansi drink.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: August 8, 2018
• Est. primary completion date: May 6, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 21 Years

Eligibility

Inclusion Criteria:

• non-smoker

• BMI between 18.5 and 24.99 kg/m2

• waist circumference less than 102 cm

• random blood glucose less than 7.8 mmol/L

• negative urine dipstick result

• not on any medications

• no family history of inherited diseases

• no heart conditions (angina, arrhythmia or heart failure)

• no history of acute medical or surgical event within the past 6 months.

Exclusion Criteria:

• pre-existing conditions such as HIV, hepatitis, inflammatory bowel diseases, diabetes mellitus, kidney disease, blood disorders (such as thalassaemia)

Related Conditions & MeSH terms

• Blood Glucose Response

Intervention

Other:
• Calamansi
250 ml of a commercially sourced calamansi drink
• Glucose
75 g of glucose dissolved in 250 ml of drinking water

Locations

Country	Name	City	State
Malaysia	Faculty of Medicine and Health Sciences	Kuching	Sarawak

Sponsors (1)

Lead Sponsor	Collaborator
University Malaysia Sarawak

Country where clinical trial is conducted

Malaysia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline blood glucose levels	Capillary blood glucose using glucometer	30, 60, 90, 120 min after drinking
Secondary	Change from baseline urinary glucose levels	Dipstick test	30, 60, 90, 120 min after drinking

External Links

•   Report of a Joint FAO/WHO Expert Consultation, Rome, Italy, 14-18 April 1997.